Synthesis of Ibuprofen Conjugated Molecular Transporter Capable of Enhanced Brain Penetration
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Biswas, Goutam | - |
dc.contributor.author | Kim, Wanil | - |
dc.contributor.author | Kim, Kyong-Tai | - |
dc.contributor.author | Cho, Junhwi | - |
dc.contributor.author | Jeong, Dongjun | - |
dc.contributor.author | Song, Keon-Hyoung | - |
dc.contributor.author | Im, Jungkyun | - |
dc.date.accessioned | 2021-08-11T16:24:17Z | - |
dc.date.available | 2021-08-11T16:24:17Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 2090-9063 | - |
dc.identifier.issn | 2090-9071 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8388 | - |
dc.description.abstract | Based on the strong evidences between inflammation and neurodegeneration, nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are considered as effective agents to reduce the risk of Alzheimer's and Parkinson's disease. However, the clinical use of NSAIDs in these diseases is limited by low brain distribution. In this study, we had synthesized ibuprofen conjugate which has good brain penetration. S-(+)-Ibuprofen was covalently attached to a molecular transporter having FITC and eight terminal guanidine groups. This conjugate showed good cellular uptake property in live cells. It was also injected into a mouse and the distribution of the compoundwas examined in each organ. The conjugate was well delivered tomouse brain indicating the conjugate is able to cross the blood-brain barrier. Our novel synthetic ibuprofen conjugate will hopefully deliver other NSAIDs into brain and is therefore applicable to the neurodegenerative diseases treatment or prevention. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Hindawi Publishing Corporation | - |
dc.title | Synthesis of Ibuprofen Conjugated Molecular Transporter Capable of Enhanced Brain Penetration | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1155/2017/4746158 | - |
dc.identifier.scopusid | 2-s2.0-85011562267 | - |
dc.identifier.wosid | 000394016300001 | - |
dc.identifier.bibliographicCitation | Journal of Chemistry, v.2017 | - |
dc.citation.title | Journal of Chemistry | - |
dc.citation.volume | 2017 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | - |
dc.subject.keywordPlus | GUANIDINIUM-RICH TRANSPORTERS | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | NSAIDS | - |
dc.subject.keywordPlus | FLURBIPROFEN | - |
dc.subject.keywordPlus | SELECTIVITY | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Ibuprofe | - |
dc.subject.keywordAuthor | Brain penetration | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.